Erythrocyte-bound apolipoprotein B after withdrawal of statin therapy

Erythrocyte-bound apolipoprotein B after withdrawal of statin therapy - EBABAST

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON38118

Enrollment

Registered

2012-03-27

Start date

2012-07-02

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypercholesterolemie Hypercholesterolemia

Interventions

Temporary discontinuation of statin therapy for a period of six weeks.

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Aged 18 years or older Use of statin therapy

Exclusion criteria

Exclusion criteria: A cardiovascular event (myocardial infarction, percutaneous coronary intervention or stroke) in the past 6 months. The use of any other lipid lowering drugs besides a statin, for example ezetimibe or a fibrate in the past 6 months.

Design outcomes

Primary

Measure	Time frame
Erythrocyte-bound apolipoprotein B before and after discontinuation of statin therapy.	—

Secondary

Measure	Time frame
none	—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)